Rhynchophylline Attenuates Neurotoxicity in Tourette Syndrome Rats

Overview

Journal Neurotox Res

Publisher Springer

Specialty Neurology

Date 2019 May 23

PMID 31115771

Citations 5

Authors

Long Hongyan

Zhang Mengjiao

Wang Chunyan

Huang Yaruo

Affiliations

Soon will be listed here.

Abstract

Tourette syndrome (TS) is a chronic neuropsychiatric disorder with clinical manifestations of involuntary and repeated muscle twitching and vocal twitching. The drugs used to treat TS are relatively limited. The aim of this study was to investigate the effects of rhynchophylline (RH) and the underlying mechanism in 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced neurotoxicity in a TS rat model. A TS model was induced with DOI. The rats were divided into control, TS, TS + tiapride (25 mg/kg), and TS + RH (20 and 40 mg/kg) groups. Behavioral tests were performed 24 h after the last administration by nodding and stereotype experiments. Interleukin-6 (IL-6), IL-1β, and tumor necrosis factor-α (TNF-α) levels in striatum and serum were detected with an enzyme-linked immunosorbent assay (ELISA). Western blot analysis was used to detect the expression levels of Toll-like receptor (TLR)/nucleotide-binding domain (NOD)-like receptor protein 3 (NLRP3)/nuclear factor kappa B (NF-κB) signal proteins in the striatum. The expression of TLR2 and NF-κB p65 subunit was detected with immunohistochemical analysis. RH may significantly improve behavioral changes in rats with DOI-induced TS and reduce the levels of inflammatory factors in serum and striatum. RH inhibited the activation of TLR/NLRP3/NF-κB signaling proteins in the striatum of TS rats. In BV2 cells, DOI-induced inflammation mediated through TLR/NLRP3/NF-κB was significantly inhibited following RH administration. The therapeutic effect of RH in TS was studied and its mechanism of action mediated via the TLR/NLRP3/NF-κB pathway was clarified in vitro and in vivo.

Citing Articles

Neuroinflammation and pathways that contribute to tourette syndrome.

Wu X, Hao J, Jiang K, Wu M, Zhao X, Zhang X Ital J Pediatr. 2025; 51(1):63.

PMID: 40022157 PMC: 11871796. DOI: 10.1186/s13052-025-01874-3.

Rhynchophylline alleviates cognitive deficits in multiple transgenic mouse models of Alzheimer's disease via modulating neuropathology and gut microbiota.

Zhong M, Xu Q, Huang M, Zhan R, Huang X, Yang W Acta Pharmacol Sin. 2025; .

PMID: 40011632 DOI: 10.1038/s41401-025-01475-0.

Probing pathways by which rhynchophylline modifies sleep using spatial transcriptomics.

Ballester Roig M, Leduc T, Dufort-Gervais J, Maghmoul Y, Tastet O, Mongrain V Biol Direct. 2023; 18(1):21.

PMID: 37143153 PMC: 10161643. DOI: 10.1186/s13062-023-00377-7.

Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway.

Wang S, Huang Z, Liu Y, Sun H, Zhou Y, Shi J Transl Lung Cancer Res. 2023; 12(3):427-445.

PMID: 37057119 PMC: 10087999. DOI: 10.21037/tlcr-22-675.

Pharmacokinetic interaction between rhynchopylline and pellodendrine via CYP450 enzymes and .

Meng Q, Cheng Y, Zhou C Pharm Biol. 2021; 59(1):1551-1555.

PMID: 34757861 PMC: 8583760. DOI: 10.1080/13880209.2021.1999988.

References

Streit W . Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006; 29(9):506-10. DOI: 10.1016/j.tins.2006.07.001. View

Peterson B, Leckman J . The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry. 1998; 44(12):1337-48. DOI: 10.1016/s0006-3223(98)00176-0. View

Dobos N, Korf J, Luiten P, Eisel U . Neuroinflammation in Alzheimer's disease and major depression. Biol Psychiatry. 2010; 67(6):503-4. DOI: 10.1016/j.biopsych.2010.01.023. View

Zhu L, Wei T, Gao J, Chang X, He H, Luo F . The cardioprotective effect of salidroside against myocardial ischemia reperfusion injury in rats by inhibiting apoptosis and inflammation. Apoptosis. 2015; 20(11):1433-43. DOI: 10.1007/s10495-015-1174-5. View

Deng X, Li H, Chen J, Li R, Qu R, Fu Q . Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice. Behav Brain Res. 2015; 291:12-19. DOI: 10.1016/j.bbr.2015.04.052. View

Peterson B, Gore J, Riddle M, Cohen D, Leckman J . Abnormal magnetic resonance imaging T2 relaxation time asymmetries in Tourette's syndrome. Psychiatry Res. 1994; 55(4):205-21. DOI: 10.1016/0165-1781(95)91246-A. View

Morer A, Chae W, Henegariu O, Bothwell A, Leckman J, Kawikova I . Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases. Brain Behav Immun. 2010; 24(7):1069-73. DOI: 10.1016/j.bbi.2010.02.007. View

Zhang B, Long H, Zhang J . [Effects of Jing'an Oral Liquid on the central neurotransmitter of multiple tics children]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012; 32(7):926-9. View

Do M, Kim H, Choi J, Jeong H . Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Free Radic Biol Med. 2014; 74:21-34. DOI: 10.1016/j.freeradbiomed.2014.06.010. View

10.

Schug T, Xu Q, Gao H, Peres-Da-Silva A, Draper D, Fessler M . Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol. 2010; 30(19):4712-21. PMC: 2950528. DOI: 10.1128/MCB.00657-10. View

11.

Zhang F, Wang S, Gan L, Vosler P, Gao Y, Zigmond M . Protective effects and mechanisms of sirtuins in the nervous system. Prog Neurobiol. 2011; 95(3):373-95. PMC: 3242010. DOI: 10.1016/j.pneurobio.2011.09.001. View

12.

Gan L, Mucke L . Paths of convergence: sirtuins in aging and neurodegeneration. Neuron. 2008; 58(1):10-4. PMC: 8245119. DOI: 10.1016/j.neuron.2008.03.015. View

13.

Deng X, Chen J, Li H, Ma Z, Ma S, Fu Q . Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats. Chem Biol Interact. 2015; 240:22-8. DOI: 10.1016/j.cbi.2015.08.001. View

14.

Leckman J . Tourette's syndrome. Lancet. 2002; 360(9345):1577-86. DOI: 10.1016/S0140-6736(02)11526-1. View

15.

Giedd J, Rapoport J, Leonard H, Richter D, Swedo S . Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. J Am Acad Child Adolesc Psychiatry. 1996; 35(7):913-5. DOI: 10.1097/00004583-199607000-00017. View

16.

Shin I, Hong J, Jeon C, Shin N, Kwon O, Kim H . Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression. Food Chem Toxicol. 2013; 62:506-13. DOI: 10.1016/j.fct.2013.09.012. View

17.

Chen T, Ma Z, Zhu L, Jiang W, Wei T, Zhou R . Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia. Mol Neurobiol. 2015; 53(9):6240-6250. DOI: 10.1007/s12035-015-9521-7. View

18.

Gorman D, Zhu H, Anderson G, Davies M, Peterson B . Ferritin levels and their association with regional brain volumes in Tourette's syndrome. Am J Psychiatry. 2006; 163(7):1264-72. PMC: 2367153. DOI: 10.1176/ajp.2006.163.7.1264. View

19.

Ma C, Kang L, Ren H, Zhang D, Kong L . Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in high fructose-fed rats. J Ethnopharmacol. 2015; 172:108-17. DOI: 10.1016/j.jep.2015.06.015. View

20.

Libert S, Guarente L . Metabolic and neuropsychiatric effects of calorie restriction and sirtuins. Annu Rev Physiol. 2012; 75:669-84. PMC: 3570673. DOI: 10.1146/annurev-physiol-030212-183800. View